PL396714A1 - Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibu - Google Patents
Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibuInfo
- Publication number
- PL396714A1 PL396714A1 PL396714A PL39671411A PL396714A1 PL 396714 A1 PL396714 A1 PL 396714A1 PL 396714 A PL396714 A PL 396714A PL 39671411 A PL39671411 A PL 39671411A PL 396714 A1 PL396714 A1 PL 396714A1
- Authority
- PL
- Poland
- Prior art keywords
- imatinib mesylate
- gelatin capsule
- capsule
- high compactness
- amount
- Prior art date
Links
- 229960003685 imatinib mesylate Drugs 0.000 title abstract 4
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 title abstract 4
- 239000007903 gelatin capsule Substances 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Przedmiotem wynalazku jest kapsulka zelatynowa twarda zawierajaca substancje aktywna mezylan imatinibu w odmianie krystalicznej a w ilosci od 90 do 100% i substancje pomocnicze w ilosci od 0 do 10% masy calkowitej wypelnienia kapsulki. Kapsulka zawiera mezylan imatinibu w ilosci odpowiadajacej od 50 do 400 mg wolnej zasady imatinibu. W korzystnym wykonaniu kapsulka zawiera sam mezylan imatinibu w postaci proszku, bez dodatku substancji pomocniczych.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL396714A PL396714A1 (pl) | 2011-10-20 | 2011-10-20 | Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL396714A PL396714A1 (pl) | 2011-10-20 | 2011-10-20 | Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL396714A1 true PL396714A1 (pl) | 2013-04-29 |
Family
ID=48536405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL396714A PL396714A1 (pl) | 2011-10-20 | 2011-10-20 | Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibu |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL396714A1 (pl) |
-
2011
- 2011-10-20 PL PL396714A patent/PL396714A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| MX2013014788A (es) | Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos. | |
| MX392839B (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| CY1116328T1 (el) | Παραγωγα 4 - αμινοπυριμιδινης και η χρηση τους ως ανταγωνιστων α2α υποδοχεων αδενοσινης | |
| MY163083A (en) | Solid forms of a pharmaceutically active substance | |
| PH12015501096A1 (en) | Composition for immediate and extended release | |
| TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
| PH12014502331B1 (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders | |
| MY161162A (en) | Immunosuppressant formulations | |
| PH12014501415A1 (en) | Heterocyclic amide derivatives as p2x7 receptor antagonists | |
| EA201300857A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
| TR201009394A2 (tr) | Geliştirilmiş montelukast formülasyonları. | |
| EA201401309A1 (ru) | Фармацевтическая композиция для ингаляции, содержащая аклидиний, и её применение | |
| PL396714A1 (pl) | Kapsulka zelatynowa o wysokiej zwartosci mezylanu imatinibu | |
| TR201007926A1 (tr) | Prasugrel tablet formülasyonları. | |
| TR201009399A2 (tr) | Hızlı çözünen efervesan rosuvastatin formülasyonları. | |
| IN2014DN07898A (pl) | ||
| PL400338A1 (pl) | Stala doustna postac dawkowania zawierajaca L-jablczan sunitynibu | |
| EA201500366A1 (ru) | Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора | |
| EA201190243A1 (ru) | Стабильная фармацевтическая композиция флударабина фосфата | |
| UA89386U (ru) | Фармацевтическая композиция с противоишемическим и антигипертензивным действием | |
| TR201008517A2 (tr) | Olmesartan medoksomil içeren ilaç formülasyonu. | |
| PL404791A1 (pl) | Stała doustna postać dawkowania zawierająca L-jabłczan sunitynibu i sposób jej wytwarzania | |
| TN2013000440A1 (en) | Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids | |
| IN2013MU01330A (pl) |